Last update:
Anti-immigrant 'public charge' policy may have contributed to rise in HIV among Hispanic ropulations
HIV & AIDS news
Anti-immigrant 'public charge' policy may have contributed to rise in HIV among Hispanic ropulations
Following the Trump administration's 2018 announcement of changes to the public charge rule that would penalize immigrants for using public benefit programs, antisanctuary counties in the U.S. saw a 16.8% increase in HIV ...
Aug 25, 2026
0
7
TB preventive treatment for people with HIV shown effective in real-world settings
Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.
Aug 18, 2026
0
5
The Medicines Patent Pool is improving access to essential medication where it's most needed
The Medicines Patent Pool (MPP) is a not-for-profit organization founded in 2010 with the support of the United Nations. Its mission is to improve access to essential medicines in low and middle-income countries (LMICs). ...
Aug 17, 2026
0
4
Can video games help personalize cognitive care for vulnerable groups?
A group of 50 participants from across the United States sat at their computers and logged in to a bespoke video game designed by Northeastern University researchers.
Aug 16, 2026
0
6
Triple-dose regimen may permanently clear HIV in infected newborns
Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon ...
Aug 10, 2026
0
128
HIV-1 proviruses may drive chronic systemic inflammation
HIV (human immunodeficiency virus) is a virus that attacks the body's immune system and remains a major global health challenge because of persistent viral reservoirs, despite effective treatments. Key factors include around ...
Aug 10, 2026
0
9
Q&A: Medicare spending on clinical care for people aging with HIV projected to rise steeply over next decade
As more Americans with HIV live into older age, Medicare spending on their care is projected to rise dramatically from $10.9 billion in 2026 to $27.3 billion in 2035, with HIV medications accounting for nearly two-thirds ...
Aug 7, 2026
0
4
Why adults living with HIV are at high risk for diabetes
A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
Aug 6, 2026
0
3
Liver disease and HIV: Study reveals major gaps in liver fibrosis screening and offers a promising solution
Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live longer and healthier lives. However, liver disease remains common in this population and is one ...
Aug 6, 2026
0
3
New model maps where HIV is concentrated and the disease is more advanced
A new biostatistical modeling approach has the potential to support health decisions by pinpointing where HIV is concentrated and where people living with HIV are showing signs of severe immune suppression or delayed treatment. ...
Aug 5, 2026
0
10
Tumor-like tissue environments could hold clues to curing HIV
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.
Aug 5, 2026
0
7
Once‑weekly HIV pill as effective as daily dose, research shows
Around 78% of people living with HIV take a daily pill to manage their infection. These drugs work by preventing HIV from multiplying.
Aug 5, 2026
0
3
Doravirine works as well as dolutegravir to suppress HIV viral load, study finds
If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the "gold standard," dolutegravir ...
Aug 3, 2026
0
5
Risk of death 21% lower in patients with HIV-related fungal disease who were given combination drug treatment
In a clinical trial of adults with HIV-related cryptococcal disease, those treated with a two-drug combination had a 21% lower risk of dying than those treated with just one drug. This is according to City St George's research ...
Aug 3, 2026
0
3
International study shows once-weekly HIV pill performs as well as daily treatment
An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as current leading daily therapies, ...
Jul 30, 2026
0
10
Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response
Scientists at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in ...
Jul 30, 2026
0
87
Four-paper series broadens sex workers' health focus beyond HIV prevention
A new four-paper series in The Lancet Public Health reflects a two-year collaboration among researchers at San Diego State University and the Johns Hopkins Bloomberg School of Public Health, the Global Network of Sex Work ...
Jul 28, 2026
0
11
How US HIV funding cuts quickly affected care in East Africa
The U.S. government's withdrawal of funding for global HIV programs in January 2025 sharply reduced the number of people entering HIV care across East Africa within weeks, according to findings led by UC San Francisco researchers.
Jul 28, 2026
0
4
HIV progress in 'real danger' as global funding plummets
The science has never been better, but political will has reached a new low: AIDS experts warned Monday that the fight against HIV was in real danger as funding fell by a fifth last year.
Jul 28, 2026
0
2
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, ...
Jul 21, 2026
0
4
Alcohol, sex and violence: A dangerous cocktail that makes young women vulnerable to HIV
South Africa has the largest HIV epidemic in the world, with adolescent girls and young women ages 15–24 at the highest risk of getting HIV. HIV prevalence among girls and women in this age group is roughly double that of ...
Jul 20, 2026
0
3
Odds of HPV-related cancers up for people with HIV and solid organ transplant recipients
The odds of human papillomavirus (HPV)-related cancers are higher among people with HIV (PWH) and solid-organ transplant recipients (SOTRs), according to a study published in JAMA Network Open.
Jul 13, 2026
0
5
Medical AI may look less biased on paper but not in practice, new study finds
Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the models may unintentionally repeat those biases in their responses. As their use increases with ...
HIV vaccine triggers broadly neutralizing antibodies in 44% of primates
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate ...
Jul 6, 2026
0
43
